Poly(ADP-ribose) Polymerase-1 (PARP-1) Contributes to the Barrier Function of a Vertebrate Chromatin Insulator

被引:10
|
作者
Aker, Mari [1 ]
Bomsztyk, Karol [2 ]
Emery, David W. [1 ,2 ,3 ]
机构
[1] Univ Washington, Div Med Genet, Seattle, WA 98195 USA
[2] Univ Washington, UW Med Lake Union, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
BETA-GLOBIN INSULATOR; ENHANCER BLOCKING; DNA-BINDING; CTCF; TRANSCRIPTION; PROTEINS; VECTORS;
D O I
10.1074/jbc.M110.174532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prototypic chromatin insulator cHS4 has proven effective in reducing silencing chromosomal position effects in a variety of settings. Most of this barrier insulator activity has been mapped to a 250-bp core region, as well as to several proteins that bind this region. However, recent studies from our laboratory demonstrated that an extended 400-bp core region of the cHS4 element is necessary to achieve full barrier insulator activity when used as a single copy in the context of recombinant gammaretroviral and lentiviral vectors. In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein binding activities associated with the distal portion of this extended core region. Affinity purification and tandem mass spectrometry studies led to the identification of one of these proteins as poly(ADP-ribose) polymerase-1 (PARP-1). The identity of this binding activity as PARP-1 was subsequently verified by a variety of biochemical studies in vitro and by chromatin immunoprecipitation studies in vivo. Functional studies with gammaretroviral reporter vectors in cell lines and primary mouse bone marrow progenitor cultures showed that cHS4 barrier activity was abrogated upon mutation of the putative PARP1-binding site or upon treatment with a PARP inhibitor, respectively. The barrier activity of the cHS4 element was also found to be abrogated in studies using bone marrow from Parp1-null mice. Taken together, this study demonstrates that binding of PARP-1 plays a key functional role in the barrier activity of the extended cHS4 insulator core element.
引用
收藏
页码:37589 / 37597
页数:9
相关论文
共 50 条
  • [11] Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis
    Nosho, Katsuhiko
    Yamamoto, Hiroyuki
    Mikami, Masashi
    Taniguchi, Hiroaki
    Takahashi, Taiga
    Adachi, Yasushi
    Imamura, Akimichi
    Imai, Kohzoh
    Shinomura, Yasuhisa
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2374 - 2381
  • [12] Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)
    Zhang, Zhimin
    Chang, Xinyue
    Zhang, Chixiao
    Zeng, Shenxin
    Liang, Meihao
    Ma, Zhen
    Wang, Zunyuan
    Huang, Wenhai
    Shen, Zhengrong
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1606 - 1615
  • [13] Involvement of poly(ADP-ribose) polymerase-1 (PARP-1) in the developement and treatment of hepatocellular carcinoma
    Quiles, R.
    Extremera, A. Ruiz
    Salmeron, J.
    Caballero, T.
    Munoz-Rueda, P.
    Casado, J.
    Oliver, F. J.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S139 - S139
  • [14] Poly (ADP-ribose) polymerase-1 (PARP-1) activity in normal and cancerous human endometrium
    Monist, M.
    Postawski, K.
    Romanek, K.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S69 - S69
  • [15] Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis:: Potential role of PARP inhibitors in cancer treatment
    Peralta-Leal, Andreina
    Rodriguez, Maria Isabel
    Oliver, Francisco Javier
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (06): : 318 - 323
  • [16] Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment
    Andreína Peralta-Leal
    María Isabel Rodríguez
    Francisco Javier Oliver
    Clinical and Translational Oncology, 2008, 10 : 318 - 323
  • [17] An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
    Wang, Ying-Qing
    Wang, Ping-Yuan
    Wang, Yu-Ting
    Yang, Guang-Fu
    Zhang, Ao
    Miao, Ze-Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (21) : 9575 - 9598
  • [18] Adenosine Thiamine Triphosphate (AThTP) Inhibits Poly(ADP-Ribose) Polymerase-1 (PARP-1) Activity
    Tanaka, Takao
    Yamamoto, Daisuke
    Sato, Takaji
    Tanaka, Sunao
    Usui, Kazuya
    Manabe, Miki
    Aoki, Yui
    Iwashima, Yasuki
    Saito, Yoshihiro
    Mino, Yoshiki
    Deguchi, Hirofumi
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2011, 57 (02) : 192 - 196
  • [19] Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
    Ferraris, Dana V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4561 - 4584
  • [20] Poly(ADP-ribose)polymerase-1 (PARP-1) expression and activity in primary human lung cells
    Ahmad, MH
    Torky, A
    Glahn, F
    Raemisch, A
    Foth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 113 - 113